Article 28 Feb 2023 Fresenius Kabi Launches STIMUFEND (pegfilgrastim-fpgk) In The United States United States Healthcare
Article 19 Dec 2022 Fresenius Kabi Announces FDA Approval Of Adalimumab Biosimilar United States Healthcare
Article 13 Oct 2022 Biogen Announces EMA Acceptance Of Tocilizumab Biosimilar Application United States Healthcare
Article 20 May 2022 Teva Receives Approval For First Ophthalmology Biosimilar In Europe United Kingdom Healthcare